Look, I am prepared to see how things go until the end of the year. And hopefully GC and his team will come through, get the uplist ready, prove Lympro is the one and only diagnostic to accurately diagnose ALZ and move forward with MANF. Hopefully all of this will help the stock and get the company the recognition we all think it deserves. But it's not unfolding the way many of us thought it would. Not by a long shot.